Low molecular weight heparin derivatives having improved anti-Xa

Details Low molecular weight heparin derivatives having improved anti-Xa Low molecular weight heparin derivatives having improved anti-Xa

1986-08-20

1990-07-17

Brown, Johnnie R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 21, 514822, A61K 31715, C08B 3710

Patent

active

049421565

ABSTRACT:
Ester derivatives of low molecular weight heparin are disclosed. These derivatives exhibit improved Anti-Xa activity in relation to global anticlotting activity.

REFERENCES:
patent: 4281108 (1981-07-01), Fussi
patent: 4303651 (1981-12-01), Lindahl
patent: 4351938 (1982-09-01), Barnett
patent: 4396762 (1983-08-01), Langer
patent: 4401662 (1983-08-01), Lormeau
patent: 4401758 (1983-08-01), Lormeau
patent: 4415559 (1983-11-01), Suzuki
patent: 4438108 (1984-03-01), Sanders
patent: 4438261 (1984-03-01), Barnett
patent: 4474770 (1984-10-01), Lormeau
patent: 4486420 (1984-12-01), Lormeau
patent: 4500519 (1985-02-01), Lormeau
patent: 4533549 (1985-08-01), Lasker
patent: 4745105 (1988-05-01), Griffin et al.
patent: 4745106 (1988-05-01), Griffin et al.
patent: 4745108 (1988-05-01), Foley et al.
Chemical Abstracts, vol. 84, 1976, No. 106000z.
Chemical Abstracts, vol. 85, 1976, No. 171536p.
Chemical Abstracts, vol. 88, 1978, No. 41689s.

Affiliated with

Also associated with

Rating

Low molecular weight heparin derivatives having improved anti-Xa does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Low molecular weight heparin derivatives having improved anti-Xa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Low molecular weight heparin derivatives having improved anti-Xa will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-95118